AgileMD vs Digistain

<p>AgileMD empowers healthcare providers by offering an intelligent clinical decision support system that predicts and prioritizes patient deterioration using FDA-cleared AI tools like eCART. It allows care teams to access updated protocols and clinical pathways quickly, reducing variability and improving outcomes across hospital settings. The platform supports seamless integration with existing EHR systems, enabling you to embed decision support and streamline order entry and documentation in your daily workflow.</p> <p>You can rapidly deploy AgileMD's solutions in days to weeks, ensuring fast impact without heavy IT reliance. With thousands of published pathways and robust reporting features, the software helps reduce mortality, length of stay, and readmissions. AgileMD complies with stringent security standards including SOC-II and HIPAA, offering a secure, cloud-based environment tailored for large health systems. This platform benefits clinical staff by enhancing care consistency, decision-making, and operational efficiency.</p>

<p>Digistain is a sophisticated AI-enabled quantitative histopathology platform designed specifically for breast cancer risk stratification. It provides clinicians with fast, clear, and easy-to-interpret results, enabling personalized treatment planning for invasive breast cancer patients. By integrating seamlessly into existing histopathology workflows and operating on routine tissue samples, Digistain delivers risk assessments within an hour, significantly reducing wait times compared to traditional methods. </p> <p>You can rely on Digistain to help reduce treatment decision times and lower costs, making advanced recurrence risk prediction more accessible. Its technology captures detailed biopsy data and employs artificial intelligence to generate a precise prognostic score, supporting multidisciplinary team discussions without replacing clinical judgment.</p>